Early safety check for experimental drug emraclidine in seniors

NCT ID NCT07219030

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study is testing an experimental drug called emraclidine in 40 healthy adults aged 65 and older. Researchers want to see how the drug moves through the body and whether it causes any side effects. Participants will receive either emraclidine or a placebo pill. This study does not aim to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Emraclidine

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Acpru /Id# 276996

    RECRUITING

    Grayslake, Illinois, 60030, United States

    Contact Phone: •••-•••-••••

  • Altasciences Clinical Los Angeles /ID# 276854

    RECRUITING

    Cypress, California, 90630, United States

  • Clinical Pharmacology Of Miami /ID# 276856

    RECRUITING

    Miami, Florida, 33172, United States

    Contact Phone: •••-•••-••••

  • K2 Medical Research, LLC /ID# 276636

    RECRUITING

    Maitland, Florida, 32751, United States